Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,056 | Dovepress* | 7,922+ | 1,515 | 9,437 | |
| PubMed Central* | 1,134 | 416 | 1,550 | ||
| Totals | 9,056 | 1,931 | 10,987 | ||
|
*Since 15 February 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar